Quantitative propagation of assembled human Tau from Alzheimer's disease brain in microfluidic neuronal cultures.


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
11 09 2020
Historique:
received: 04 03 2020
revised: 07 07 2020
pubmed: 24 7 2020
medline: 28 1 2021
entrez: 24 7 2020
Statut: ppublish

Résumé

Tau aggregation and hyperphosphorylation is a key neuropathological hallmark of Alzheimer's disease (AD), and the temporospatial spread of Tau observed during clinical manifestation suggests that Tau pathology may spread along the axonal network and propagate between synaptically connected neurons. Here, we have developed a cellular model that allows the study of human AD-derived Tau propagation from neuron to neuron using microfluidic devices. We show by using high-content imaging techniques and an in-house developed interactive computer program that human AD-derived Tau seeds rodent Tau that propagates trans-neuronally in a quantifiable manner in a microfluidic culture model. Moreover, we were able to convert this model to a medium-throughput format allowing the user to handle 16 two-chamber devices simultaneously in the footprint of a standard 96-well plate. Furthermore, we show that a small molecule inhibitor of aggregation can block the trans-neuronal transfer of Tau aggregates, suggesting that the system can be used to evaluate mechanisms of Tau transfer and find therapeutic interventions.

Identifiants

pubmed: 32699110
pii: S0021-9258(17)49965-0
doi: 10.1074/jbc.RA120.013325
pmc: PMC7489902
pii:
doi:

Substances chimiques

Amyloid beta-Peptides 0
MAPT protein, human 0
tau Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

13079-13093

Informations de copyright

© 2020 Katsikoudi et al.

Déclaration de conflit d'intérêts

Conflict of interest—The authors declare that they have no conflicts of interest with the contents of this article.

Références

Sci Rep. 2017 Nov 16;7(1):15692
pubmed: 29146949
Lab Chip. 2013 Feb 21;13(4):509-21
pubmed: 23306275
J Neurosci. 2016 Jan 20;36(3):762-72
pubmed: 26791207
Nat Neurosci. 2015 Nov;18(11):1584-93
pubmed: 26436904
Acta Neuropathol. 2014 Feb;127(2):299-301
pubmed: 24362441
Biomed Microdevices. 2009 Dec;11(6):1145-53
pubmed: 19554452
Acta Neuropathol Commun. 2014 Jan 30;2:14
pubmed: 24479894
Cell Rep. 2018 May 15;23(7):2039-2055
pubmed: 29768203
Acta Neuropathol. 2016 Apr;131(4):549-69
pubmed: 26739002
J Neurosci. 2015 Oct 21;35(42):14234-50
pubmed: 26490863
Integr Biol (Camb). 2014 Jun;6(6):636-44
pubmed: 24796407
Acta Neuropathol. 2006 Oct;112(4):389-404
pubmed: 16906426
Cell. 2016 Feb 11;164(4):603-15
pubmed: 26871627
Int J Dev Biol. 1994 Mar;38(1):13-25
pubmed: 8074993
Lab Chip. 2019 Apr 9;19(8):1484-1489
pubmed: 30899932
Acta Neuropathol. 2014 May;127(5):667-83
pubmed: 24531916
Acta Neuropathol. 2011 May;121(5):589-95
pubmed: 21516512
J Exp Med. 2016 Nov 14;213(12):2635-2654
pubmed: 27810929
Acta Neuropathol. 2013 Jun;125(6):795-813
pubmed: 23604588
Mol Neurodegener. 2017 Jun 29;12(1):50
pubmed: 28662669
Acta Neuropathol. 1991;82(4):239-59
pubmed: 1759558
Acta Neuropathol. 2019 Oct;138(4):575-595
pubmed: 31165254
Annu Rev Cell Dev Biol. 2014;30:503-33
pubmed: 25288117
Nat Rev Neurosci. 2016 Apr;17(4):251-60
pubmed: 26988744
Mol Neurodegener. 2017 Jan 13;12(1):5
pubmed: 28086931
Stem Cell Reports. 2019 Feb 12;12(2):230-244
pubmed: 30639210
Acta Neuropathol. 2015 Nov;130(5):619-31
pubmed: 26439832
Nat Commun. 2015 Oct 13;6:8490
pubmed: 26458742
Brain Res Dev Brain Res. 1994 Aug 12;81(1):77-88
pubmed: 7805289
Free Radic Biol Med. 2013 Sep;62:90-101
pubmed: 23200807
Proc Natl Acad Sci U S A. 1990 Aug;87(15):5827-31
pubmed: 2116006
Acta Neuropathol. 1996 Aug;92(2):197-201
pubmed: 8841666
Nat Methods. 2005 Aug;2(8):599-605
pubmed: 16094385
Front Neurosci. 2018 Apr 24;12:267
pubmed: 29740275
Acta Neuropathol. 2018 Jul;136(1):57-67
pubmed: 29752551
J Biol Chem. 2013 Jan 18;288(3):1856-70
pubmed: 23188818
J Alzheimers Dis. 2010;19(2):721-33
pubmed: 20110615
Biochim Biophys Acta. 2005 Jan 3;1739(2-3):240-50
pubmed: 15615642
Nat Neurosci. 2016 Aug;19(8):1085-92
pubmed: 27322420
Chem Asian J. 2018 Nov 16;13(22):3437-3447
pubmed: 30117682
Brain. 2015 Jun;138(Pt 6):1738-55
pubmed: 25833819
Cell Rep. 2015 May 26;11(8):1176-83
pubmed: 25981034
Ann Neurol. 2016 Sep;80(3):355-67
pubmed: 27351289

Auteurs

Antigoni Katsikoudi (A)

Department of Neuroscience, Eli Lilly & Company Limited, Erl Wood Manor, Windlesham, Surrey, United Kingdom.

Elena Ficulle (E)

Department of Neuroscience, Eli Lilly & Company Limited, Erl Wood Manor, Windlesham, Surrey, United Kingdom.

Annalisa Cavallini (A)

Department of Neuroscience, Eli Lilly & Company Limited, Erl Wood Manor, Windlesham, Surrey, United Kingdom.

Gary Sharman (G)

Department of Neuroscience, Eli Lilly & Company Limited, Erl Wood Manor, Windlesham, Surrey, United Kingdom.

Amelie Guyot (A)

Department of Neuroscience, Eli Lilly & Company Limited, Erl Wood Manor, Windlesham, Surrey, United Kingdom.

Michele Zagnoni (M)

Centre for Microsystems & Photonics, Department of Electronic and Electrical Engineering, University of Strathclyde, Glasgow, United Kingdom.

Brian J Eastwood (BJ)

Department of Neuroscience, Eli Lilly & Company Limited, Erl Wood Manor, Windlesham, Surrey, United Kingdom.

Michael Hutton (M)

Department of Neuroscience, Eli Lilly & Company Limited, Erl Wood Manor, Windlesham, Surrey, United Kingdom.

Suchira Bose (S)

Department of Neuroscience, Eli Lilly & Company Limited, Erl Wood Manor, Windlesham, Surrey, United Kingdom. Electronic address: bose_suchira@lilly.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH